Ryan Specialty Holdings, Inc. (NYSE:RYAN) Given Average Rating of “Hold” by Analysts

Ryan Specialty Holdings, Inc. (NYSE:RYAN) has been given a consensus recommendation of “Hold” by the twelve ratings firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and six have given a buy recommendation to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $74.40.

A number of research firms have recently commented on RYAN. Keefe, Bruyette & Woods dropped their price objective on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating for the company in a research note on Friday, January 10th. Wells Fargo & Company dropped their price objective on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 14th. Barclays upped their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. Morgan Stanley began coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They set an “overweight” rating and a $90.00 target price for the company. Finally, Bank of America increased their target price on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th.

Ryan Specialty Price Performance

NYSE:RYAN opened at $65.66 on Friday. The firm has a market cap of $17.19 billion, a price-to-earnings ratio of 85.27, a price-to-earnings-growth ratio of 1.16 and a beta of 0.72. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The company’s 50-day moving average is $67.63 and its two-hundred day moving average is $66.12. Ryan Specialty has a 12-month low of $42.21 and a 12-month high of $75.97.

Ryan Specialty (NYSE:RYAN) last released its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.41. The company had revenue of $604.69 million for the quarter, compared to analyst estimates of $602.04 million. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The firm’s quarterly revenue was up 20.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.32 EPS. Research analysts expect that Ryan Specialty will post 1.82 EPS for the current year.

Ryan Specialty Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were paid a dividend of $0.11 per share. This represents a $0.44 annualized dividend and a dividend yield of 0.67%. The ex-dividend date was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio (DPR) is currently 57.14%.

Insider Activity

In related news, Director David P. Bolger sold 7,055 shares of the firm’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total transaction of $500,058.40. Following the transaction, the director now directly owns 78,149 shares in the company, valued at $5,539,201.12. This trade represents a 8.28 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Mark Stephen Katz sold 14,790 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $71.39, for a total value of $1,055,858.10. Following the transaction, the executive vice president now owns 12,386 shares in the company, valued at $884,236.54. This trade represents a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 261,402 shares of company stock worth $17,435,489. 11.10% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Ryan Specialty

A number of hedge funds have recently added to or reduced their stakes in RYAN. Principal Financial Group Inc. lifted its stake in Ryan Specialty by 148.9% in the third quarter. Principal Financial Group Inc. now owns 851,704 shares of the company’s stock valued at $56,545,000 after buying an additional 509,548 shares during the last quarter. Jennison Associates LLC lifted its stake in Ryan Specialty by 60.2% in the third quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock valued at $68,054,000 after buying an additional 385,366 shares during the last quarter. Eagle Asset Management Inc. lifted its stake in Ryan Specialty by 32.1% in the third quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company’s stock valued at $98,555,000 after buying an additional 335,180 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Ryan Specialty by 43.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company’s stock valued at $62,286,000 after buying an additional 286,380 shares during the last quarter. Finally, Driehaus Capital Management LLC bought a new stake in Ryan Specialty in the second quarter valued at $16,313,000. 84.82% of the stock is currently owned by institutional investors.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.